Asia Medical and Agricultural Laboratory and Research Center Public Company (AMARC) Fair Value & Analysis
Technology · TH · Market cap 1.4B THB
Fair value as of: Jun 24, 2026
Analysis
Asia Medical and Agricultural Laboratory and Research Center Public Company (AMARC) currently trades at 3.30 THB, while our model-based Fair Value estimate is 6.21 THB — implying the stock looks roughly 88.2% undervalued today. We read business quality at 95/100 (high quality), in the Technology sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
Asia Medical and Agricultural Laboratory and Research Center Public Company Limited provides scientific services for the agriculture, food, pharmaceutical, and environment industries in Thailand. The company offers one stop and customized services, and quality, contaminants, additive services for meat and meat products, fats and oils, pet food, feedstuffs and feed raw materials, aquaculture aquatic animals and aquatic animal products, crops, foods, beverages, nutrition label, product shelf life, food contact materials, water ice, potable water, and utility water. It also provides fertilizer, hazardous substances, and research and development services for fertilizer, hazardous substance used in agriculture, soil, and water, as well as efficacy and residue testing of pesticide; testing and analyzing the quality of modern drugs, cannabis, hemp, herbs, and cosmetics; and checks the quality of water for consumption, production process water, and wastewater, as well as soil and air. In ad…
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Asia Medical and Agricultural Laboratory and Research Center Public Company (AMARC) undervalued?
What is the fair value of AMARC?
What is the quality score of AMARC?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.